Search This Blog

Monday, October 12, 2026

ANI Phase 4 fluocinolone implant met co-primary endpoints in chronic non-infectious posterior uveitis

 

ANI Pharmaceuticals' Phase 4 SYNCHRONICITY trial of fluocinolone implant met co-primary endpoints in chronic non-infectious posterior uveitis with 24‑month efficacy

  • Safety profile in chronic non-infectious uveitis of the posterior segment was consistent with prior ILUVIEN studies
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)